Tiptapp Secures €1 Million to Drive Sustainable Urban Logistics in Berlin

Tiptapp, the innovative Swedish platform revolutionizing urban logistics, has announced a significant €1 million funding boost aimed at enhancing its marketing initiatives across Berlin and broader Germany. This recent financial injection brings Tiptapp’s total funding to an impressive €8.5 million. Launched in 2016, Tiptapp offers a unique solution for urban dwellers by connecting individuals needing…

Read More

CTERA Secures $80 Million Growth Investment from PSG Equity, Expands Hybrid Cloud Data Platform

CTERA, a pioneer in hybrid cloud data management, has announced a significant milestone with the closing of an $80 million funding round led by PSG Equity, a prominent growth equity firm specializing in software and technology-enabled services. This investment, comprising both primary and secondary funding, underscores CTERA’s strategic focus on enhancing its hybrid cloud data…

Read More

Scaling the Future: Bee Maps Lands $32 Million to Transform Mapping Through AI and Decentralization

Bee Maps, powered by Hivemapper, has announced a significant $32 million funding round led by Pantera Capital, with participation from LDA Capital, Borderless Capital, and Ajna Capital. This investment underscores strong market confidence in Bee Maps’ mission to revolutionize geospatial data through its pioneering decentralized AI mapping platform. In an era where real-time, hyper-accurate maps…

Read More

ÄIO Secures €6.1M Funding to Pioneer Sustainable Oils from Wood and Agricultural Residues

In a remarkable stride towards sustainability, biotechnology startup ÄIO has successfully raised €6.1 million in funding, backed by a consortium of venture capital firms including Voima Ventures, 2C Ventures, SmartCap, and Nordic Foodtech VC. This significant investment will enable the establishment of a demonstration plant in Estonia, aimed at producing eco-friendly oils and fats derived…

Read More

Indoor Mapping App WYA Raises £2.5 Million Pre-Seed Funding to Enhance Event Safety

In a significant advancement for event safety, Where You At (WYA), a female-founded indoor mapping platform, has secured £2.5 million in Pre-Seed funding. This innovative app utilizes a patented mesh technology to facilitate real-time location sharing and communication, addressing the crucial issue of connectivity during crowded events. Founded by Tamzin Lent, WYA emerged from a…

Read More

Syntetica Secures €4.2M to Revolutionize Nylon Recycling: Pioneering Sustainable Fashion with Advanced Depolymerisation Technology

Syntetica, a trailblazing startup in the field of nylon recycling, has announced a significant milestone with the successful closure of a €4.2 million Seed funding round. Led by EQT Ventures and backed by a consortium of investors including Peugeot and ETAM family offices, Syntetica is poised to redefine sustainability in the textile industry with its…

Read More

Brenus Pharma Secures $25 Million to Propel Clinical Trials for Precision Cancer Vaccines

In a significant advancement for cancer treatment, Brenus Pharma has announced the successful completion of a $25 million Series A financing round, aimed at accelerating the development of its precision cancer vaccines. This round was led by a consortium of French investors, in partnership with Belgian investment funds, and will primarily fund the first Phase…

Read More

Rob Rebak Named CEO of Mosaic Diagnostics, A Leader in Personalized Healthcare Diagnostics

Mosaic Diagnostics, renowned for its innovative approach in personalized, data-driven healthcare diagnostics, proudly announces the appointment of Rob Rebak as its new Chief Executive Officer. With a distinguished career spanning more than three decades in the healthcare industry, Rebak brings a wealth of experience and a proven track record in driving growth, value, and innovation….

Read More

Excellergy Raises $70M to Rewrite the Allergy Playbook with Trifunctional Biologics

A new force has entered the allergy‑therapeutics arena. Excellergy has announced a bold $70 million Series A round designed to advance its lead candidates—“trifunctional” Effector Cell Response Inhibitors (ECRIs)—toward clinical proof. The molecules aim to simultaneously strip IgE from bound immune cells, neutralize free IgE, and tamp down the receptor expression that fuels allergic cascades….

Read More